All Pharma News
price-trendAsk Us
J&J finds another path for Momenta drug in rare fetal disorder

J&J finds another path for Momenta drug in rare fetal disorder
James Waldron FIERCE BIOTECH
07 Feb 2023
Share Share
J&J, Momenta Pharma file patent infringement lawsuit against Natco, Mylan

J&J, Momenta Pharma file patent infringement lawsuit against Natco, Mylan
BUSINESS-STANDARD
26 May 2022
Share Share
Provention hires 3rd exec as it awaits FDA meeting for lead drug

Provention hires 3rd exec as it awaits FDA meeting for lead drug
K. LaHucik FIERCEBIOTECH
18 Nov 2021
Share Share
J&J, free from rival bidders, made Momenta wait on $6.5B deal

J&J, free from rival bidders, made Momenta wait on $6.5B deal
Nick Paul Taylor FIERCEBIOTECH
03 Sep 2020
Share Share
Enthused by PhII autoimmune data, J&J kept Momenta waiting in $6.5B buyout

Enthused by PhII autoimmune data, J&J kept Momenta waiting in $6.5B buyout
Amber Tong ENDPTS
02 Sep 2020
Share Share
Momenta Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN

Momenta Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFN
GLOBENEWSWIRE
27 Jul 2020
Share Share
Momenta Pharma drug improves symptoms in patients with myasthenia gravis

Momenta Pharma drug improves symptoms in patients with myasthenia gravis
Adam Feuerstein PRESS RELEASE
15 Jun 2020
Share Share
Momenta clears a PhII hurdle on nipo but one big rival remains well in the lead

Momenta clears a PhII hurdle on nipo but one big rival remains well in the lead
John Carroll ENDPTS
15 Jun 2020
Share Share